Browse by Changes

Prescriber Bag

Advance Notices

1 February 2023

Deletion – Brand

3497C APO-Salbutamol, TX – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules

1 April 2023

Deletion – Brand

3479D DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules
3480E DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules

General Pharmaceutical Benefits

Additions

Addition – Item

13200R BECLOMETASONE + FORMOTEROL (EFORMOTEROL) + GLYCOPYRRONIUM, beclometasone dipropionate 200 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations (Trimbow)
13199Q DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)
13202W DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)
13177M FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo)
13183W FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo)
13195L FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo)
13198P FARICIMAB, faricimab 28.8 mg/0.24 mL injection, 0.24 mL vial (Vabysmo)
11049M SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE MONOHYDRATE + CITRIC ACID, sodium chloride 470 mg + potassium chloride 300 mg (potassium 4 mmol) + glucose monohydrate 3.56 g + sodium acid citrate 530 mg powder for oral liquid, 10 x 4.9 g sachets (O.R.S.)

Addition – Brand

5542Q Vizo-PF Dorzolatim, AE – DORZOLAMIDE + TIMOLOL, dorzolamide 2% + timolol 0.5% eye drops, 5 mL
8567X Vizo-PF Dorzolatim, AE – DORZOLAMIDE + TIMOLOL, dorzolamide 2% + timolol 0.5% eye drops, 5 mL
9432K Escitalopram Sandoz, HX – ESCITALOPRAM, escitalopram 10 mg tablet, 28
9433L Escitalopram Sandoz, HX – ESCITALOPRAM, escitalopram 20 mg tablet, 28
8651H Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
10004M Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
10009T Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
11266Y Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
9417P Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
9420T Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
9488J Sunitinib MSN, LR – SUNITINIB, sunitinib 12.5 mg capsule, 28
11253G Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
2842N Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
2959R Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
9418Q Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
9421W Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
9489K Sunitinib MSN, LR – SUNITINIB, sunitinib 25 mg capsule, 28
10459L Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
10464R Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
10473F Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
10503T Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
10504W Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
11256K Sunitinib MSN, LR – SUNITINIB, sunitinib 37.5 mg capsule, 28
10010W Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28
11250D Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28
2837H Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28
9419R Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28
9422X Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28
9490L Sunitinib MSN, LR – SUNITINIB, sunitinib 50 mg capsule, 28

Addition – Equivalence Indicator

8651H CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL

Addition – Note

12910L MOLNUPIRAVIR, molnupiravir 200 mg capsule, 40 (Lagevrio)

Deletions

Deletion – Brand

8245Y Fera, AS – LETROZOLE, letrozole 2.5 mg tablet, 30
1746X Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
5196L Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
5224Y Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
8784H Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
12001P Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
12001P Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
1760P Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
1760P Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
5260W Biaxsig, AV – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
5260W Rulide, SW – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10
11993F Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5
5261X Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5
8016X Biaxsig, AV – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5

Deletion – Note

2856H PHENELZINE, phenelzine 15 mg tablet, 100 (Nardil)

Alterations

Alteration – Restriction

12667Q BROLUCIZUMAB, brolucizumab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Beovu)
12683M DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)
5449T LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth)
8374R LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 10)
5450W LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth)
8375T LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 20)
12910L MOLNUPIRAVIR, molnupiravir 200 mg capsule, 40 (Lagevrio)
12996B NIRMATRELVIR (&) RITONAVIR, nirmatrelvir 150 mg tablet [4] (&) ritonavir 100 mg tablet [2], 5 x 6 (Paxlovid)

Alteration – Restriction Level

From To
5449T LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) streamlined restricted
8374R LEFLUNOMIDE, leflunomide 10 mg tablet, 30 (Arabloc, Arava, Ataris 10, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 10) streamlined restricted
5450W LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth) streamlined restricted
8375T LEFLUNOMIDE, leflunomide 20 mg tablet, 30 (Arava, Ataris 20, Leflunomide APOTEX, Leflunomide Sandoz, Leflunomide generichealth, Lunava 20) streamlined restricted

Alteration – Manufacturer Code

From To
8179L Anastrol – ANASTROZOLE, anastrozole 1 mg tablet, 30 AS TB

Supply Only

When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.

Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.

Further information on Supply Only arrangements is available at www.pbs.gov.au

Supply Only Commencing 1 January 2023

11564P ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000)
11581M ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000)
11575F ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500)
11584Q ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500)
11563N ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000)
11569X ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000)
11562M ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500)
11568W ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500)

Advance Notices

1 February 2023

Deletion – Brand

3423E Byetta 5 microgram, AP – EXENATIDE, exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device
3424F Byetta 10 microgram, AP – EXENATIDE, exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
1692C ARX-Nitrofurantoin, XT – NITROFURANTOIN, nitrofurantoin 50 mg capsule, 30
1693D ARX-Nitrofurantoin, XT – NITROFURANTOIN, nitrofurantoin 100 mg capsule, 30
2001H APO-Salbutamol, TX – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules
8885P Imigran FDT, AS – SUMATRIPTAN, SUMATRIPTAN Tablet (fast disintegrating) 50 mg (as succinate), 2

1 March 2023

Deletion – Brand

1750D Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
5522P Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
9218E Ircal, PE – PARAFFIN, paraffin 1 g/g eye ointment, 2 x 3.5 g
1897W Feldene, PF – PIROXICAM, piroxicam 10 mg capsule, 50
5203W Feldene, PF – PIROXICAM, piroxicam 10 mg capsule, 50

1 April 2023

Deletion – Brand

9092M Strattera, LY – ATOMOXETINE, atomoxetine 10 mg capsule, 28
9093N Strattera, LY – ATOMOXETINE, atomoxetine 18 mg capsule, 28
9094P Strattera, LY – ATOMOXETINE, atomoxetine 25 mg capsule, 28
9095Q Strattera, LY – ATOMOXETINE, atomoxetine 40 mg capsule, 28
9096R Strattera, LY – ATOMOXETINE, atomoxetine 60 mg capsule, 28
9289X Strattera, LY – ATOMOXETINE, atomoxetine 80 mg capsule, 28
9290Y Strattera, LY – ATOMOXETINE, atomoxetine 100 mg capsule, 28
9299K Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 4 mg modified release tablet, 14
9406C Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 8 mg modified release tablet, 14
9407D Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 16 mg modified release tablet, 14
9408E Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 32 mg modified release tablet, 14
9409F Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 64 mg modified release tablet, 14
2436F Natrilix, SE – INDAPAMIDE, indapamide hemihydrate 2.5 mg tablet, 90
8196J Sporanox, JC – ITRACONAZOLE, itraconazole 100 mg capsule, 60
1644M DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules
1645N DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules
1647Q DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules
5168B DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules
5169C DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules
5170D DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules

1 August 2023

Deletion – Brand

2418G Amitriptyline Alphapharm 25, MQ – AMITRIPTYLINE, amitriptyline hydrochloride 25 mg tablet, 50
1358L Dosulepin Mylan, MQ – DOSULEPIN (DOTHIEPIN), dosulepin (dothiepin) hydrochloride 75 mg tablet, 30
1500Y Hydrocortisone Mylan 20, MQ – HYDROCORTISONE, hydrocortisone 20 mg tablet, 60

Palliative Care

Advance Notices

1 April 2023

Deletion – Brand

12473L Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 16 mg modified release tablet, 14
12482Y Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 8 mg modified release tablet, 14
12496Q Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 4 mg modified release tablet, 14
12535R Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 64 mg modified release tablet, 14
12543E Jurnista, JC – HYDROMORPHONE, hydromorphone hydrochloride 32 mg modified release tablet, 14
12499W DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules
12503C DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules
12548K DBL Morphine Sulfate Pentahydrate, PF – MORPHINE, morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Brand

6364Y Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
6371H Zoledronic Acid Accord, OC – ZOLEDRONIC ACID, zoledronic acid 4 mg/5 mL injection, 5 mL vial

Addition – Equivalence Indicator

6364Y CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL

Addition – Note

10417G POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12668R POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
10386P POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12661J POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)

Deletions

Deletion – Equivalence Indicator

10417G Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
10417G Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
10417G Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
12668R Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
12668R Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
12668R Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
10386P Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10386P Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10386P Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
12661J Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12661J Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12661J Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 14

Alterations

Alteration – Note

5827Q ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade)
5828R ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade)
9697J ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate)
9699L ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate)

Alteration – Restriction

5827Q ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade)
5828R ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade)
10417G POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12668R POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
10386P POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12661J POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
9697J ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate)
9699L ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate)

Alteration – Number of Repeats

From To
9697J ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) 0 5
9699L ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) 0 5

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Brand

9500B Pharmacor Mycophenolate, CR – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
9653C Zoledronic Acid Accord, OC – ZOLEDRONIC ACID, zoledronic acid 4 mg/5 mL injection, 5 mL vial

Addition – Equivalence Indicator

9500B CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL

Addition – Note

10406Q POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12666P POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
10387Q POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12665N POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)

Deletions

Deletion – Equivalence Indicator

10406Q Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
10406Q Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
10406Q Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
12666P Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
12666P Pomalyst, CJ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
12666P Pomolide, JU – POMALIDOMIDE, pomalidomide 3 mg capsule, 14
10387Q Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10387Q Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10387Q Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
12665N Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12665N Pomalyst, CJ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12665N Pomolide, JU – POMALIDOMIDE, pomalidomide 4 mg capsule, 14

Alterations

Alteration – Note

5825N ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade)
5826P ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade)
9696H ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate)
9698K ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate)

Alteration – Restriction

5825N ELTROMBOPAG, eltrombopag 25 mg tablet, 28 (Revolade)
5826P ELTROMBOPAG, eltrombopag 50 mg tablet, 28 (Revolade)
10406Q POMALIDOMIDE, pomalidomide 3 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12666P POMALIDOMIDE, pomalidomide 3 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
10387Q POMALIDOMIDE, pomalidomide 4 mg capsule, 21 (Pomalidomide Sandoz, Pomalyst, Pomolide)
12665N POMALIDOMIDE, pomalidomide 4 mg capsule, 14 (Pomalidomide Sandoz, Pomalyst, Pomolide)
9696H ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate)
9698K ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate)

Alteration – Number of Repeats

From To
9696H ROMIPLOSTIM, romiplostim 250 microgram injection, 1 vial (Nplate) 0 5
9698K ROMIPLOSTIM, romiplostim 500 microgram injection, 1 vial (Nplate) 0 5

Repatriation Pharmaceutical Benefits

Deletions

Deletion – Brand

10582Y Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
10585D Mendeleev Paracetamol, HX – PARACETAMOL, paracetamol 500 mg tablet, 100
 

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Restriction

12219D BORTEZOMIB,
bortezomib 1 mg injection, 1 vial (Bortezomib Accord);
bortezomib 1 mg injection, 1 vial (Bortezomib Juno);
bortezomib 1 mg injection, 1 vial (DBL Bortezomib);
bortezomib 1 mg injection, 1 vial (Velcade);
bortezomib 2.5 mg injection, 1 vial (Bortezomib Juno);
bortezomib 2.5 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3 mg injection, 1 vial (Velcade);
bortezomib 3.5 mg injection, 1 vial (Bortezom);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Accord);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Baxter);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Juno);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Sandoz);
bortezomib 3.5 mg injection, 1 vial (Bortezomib-AFT);
bortezomib 3.5 mg injection, 1 vial (Bortezomib-Dr.Reddy's);
bortezomib 3.5 mg injection, 1 vial (BORTEZOMIB-TEVA);
bortezomib 3.5 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3.5 mg injection, 1 vial (Velcade);
bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Accord);
bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Ever Pharma);
bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Accord);
bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Ever Pharma)

Deletions

Deletion – Brand

7249M Irinotecan Kabi, PK – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial
7254T Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 30 mg/5 mL injection, 5 mL vial
7254T Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 300 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Restriction

13160P CEMIPLIMAB,
cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo)
12230Q DARATUMUMAB,
daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex);
daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex)
7230M DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN)

Alteration – Restriction Level

From To
7230M DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) 		streamlined unrestricted
 

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Restriction

12227M BORTEZOMIB,
bortezomib 1 mg injection, 1 vial (Bortezomib Accord);
bortezomib 1 mg injection, 1 vial (Bortezomib Juno);
bortezomib 1 mg injection, 1 vial (DBL Bortezomib);
bortezomib 1 mg injection, 1 vial (Velcade);
bortezomib 2.5 mg injection, 1 vial (Bortezomib Juno);
bortezomib 2.5 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3 mg injection, 1 vial (Velcade);
bortezomib 3.5 mg injection, 1 vial (Bortezom);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Accord);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Baxter);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Juno);
bortezomib 3.5 mg injection, 1 vial (Bortezomib Sandoz);
bortezomib 3.5 mg injection, 1 vial (Bortezomib-AFT);
bortezomib 3.5 mg injection, 1 vial (Bortezomib-Dr.Reddy's);
bortezomib 3.5 mg injection, 1 vial (BORTEZOMIB-TEVA);
bortezomib 3.5 mg injection, 1 vial (DBL Bortezomib);
bortezomib 3.5 mg injection, 1 vial (Velcade);
bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Accord);
bortezomib 2.5 mg/mL injection, 1 mL vial (Bortezomib Ever Pharma);
bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Accord);
bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial (Bortezomib Ever Pharma)

Deletions

Deletion – Brand

4451G Irinotecan Kabi, PK – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial
4567J Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 30 mg/5 mL injection, 5 mL vial
4567J Paclitaxel Kabi, PK – PACLITAXEL, paclitaxel 300 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Restriction

13169D CEMIPLIMAB,
cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo)
12228N DARATUMUMAB,
daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex);
daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex)
4364Q DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN)

Alteration – Restriction Level

From To
4364Q DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL),
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Caelyx);
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, 25 mL vial (Liposomal Doxorubicin SUN) 		streamlined unrestricted
 

Related Pharmaceutical Benefits for Public Hospital use

Additions

Addition – Item

13201T DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)
13203X DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)

Alterations

Alteration – Restriction

12746W DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC)